Abstract:Objective:To measure the expression level of kinesin superfamily 23 (KIF23) in lung adenocarcinomas (LUAD), and identify its correlation with the prognosis of LUAD, to explore the effects of KIF23 on regulating proliferation, migration and invasion of LUAD cells.Methods:Gene Expression Profiling Interactive Analysis (GEPIA) database was used to analyze KIF23 expression in LUAD samples.The Kaplan-Meier Plotter was used to analyze the life cycle of LUAD patients, and Gene set enrichment analysis (GSEA) was performed for KIF23.Quantitative polymerase chain reaction (qPCR) and Western blot were performed to detect the mRNA and protein expressions of KIF23 in LUAD cell lines after being transfected with shRNA-KIF23.Cell migration and invasion were detected by Transwell assay, and cell proliferation was detected by Cell Counting kit-8 (CCK-8)assay.In LUAD tissue samples and para-carcinoma tissues, positive expressions of KIF23 were detected by immunohistochemistry.Results:KIF23 was significantly upregulated in LUAD samples ( n=515) compared with those of normal lung tissues ( n=59) in GEPIA database ( P<0.001).Kaplan-Meier Plotter suggested that the patients with high expression of KIF23 had significant lower overall survival (OS) compared with the patients with low expression of KIF23 ( HR=1.35, 95% CI: 1.06-1.70, P=0.013).GSEA analysis implied that mitotic spindle pathway and G2/M checkpoint pathway were significantly enriched in LUAD patients expressing high levels of KIF23.Transwell results showed that the migratory rate of H1299 and A549 cells transfected with shRNA-KIF23 was significantly lower than that of controls ( F=55.45 and 64.93, respectively, both P<0.001).Consistently, the invasive rate of H1299 and A549 cells transfected with shRNA-KIF23 was also lower than that of the control Group( F=68.16 and 175.00, respectively, both P<0.001).CCK-8 assay illustrated a significant decline of proliferation ability in cell lines of H1299 and A549 cells with KIF23 knockdown on day 2-5 than that of controls (H1299 cells, F=72.74, 113.60, 46.93 and 93.48, respectively; A549 cells, F=31.07, 103.80, 92.83 and 130.20, respectively, both P<0.001).Immunohistochemistry result demonstrated a significantly higher positive expression of KIF23 in LUAD samples than that of para-carcinoma tissues ([53.06±10.78] vs [33.03±11.98], t=9.63, P<0.001). Conclusions:KIF23, which promoted the tumorigenesis and progression of LUAD via improving the LUAD cells ability of migration, invasion and proliferation, is highly expressed in LUAD compared with normal lung tissues.It can be served as a new therapeutic target and prognostic prediction biomarker of LUAD.

Overexpression of KIF20A confers malignant phenotype of lung adenocarcinoma by promoting cell proliferation and inhibiting apoptosis

An evaluation of KIF20A as a prognostic factor and therapeutic target for lung adenocarcinoma using integrated bioinformatics analysis

FOXP3 Targets KIF5A to Increase Lactate Production and Promote Docetaxel Resistance in Lung Adenocarcinoma

Increased Kif15 Expression Predicts A Poor Prognosis In Patients With Lung Adenocarcinoma

A pan-cancer exploration of kinesin family member 20A (KIF20A)'s oncogenic activity in human tumors

Retracted: KIF20A Silence Inhibits the Migration, Invasion and Proliferation of Non‐small Cell Lung Cancer and Regulates the JNK Pathway

Genome‑wide investigation of the clinical significance and prospective molecular mechanisms of kinesin family member genes in patients with lung adenocarcinoma

Upregulation of KIF20A promotes tumor proliferation and invasion in renal clear cell carcinoma and is associated with adverse clinical outcome

KIF20A Affects the Prognosis of Bladder Cancer by Promoting the Proliferation and Metastasis of Bladder Cancer Cells.

Co-expression Network Analysis Identified KIF2C in Association with Progression and Prognosis in Lung Adenocarcinoma.

The overexpression of KIFC1 was associated with the proliferation and prognosis of non-small cell lung cancer.

Biological functions of KIF23 in lung adenocarcinomas validated by bioinformatic analyses

Aberrant KIF20A expression might independently predict poor overall survival and recurrence-free survival of hepatocellular carcinoma.

Aberrant KIF20A Expression is Associated with Adverse Clinical Outcome and Promotes Tumor Progression in Prostate Cancer.

KIF20A is associated with clinical prognosis and synergistic effect of gemcitabine combined with ferroptosis inducer in lung adenocarcinoma

High Expression of KIF20A Is Associated with Poor Overall Survival and Tumor Progression in Early-Stage Cervical Squamous Cell Carcinoma

Overexpression Of Kinesin Family Member 20a Correlates With Disease Progression And Poor Prognosis In Human Nasopharyngeal Cancer: A Retrospective Analysis Of 105 Patients

KLRB1 expression is associated with lung adenocarcinoma prognosis and immune infiltration and regulates lung adenocarcinoma cell proliferation and metastasis through the MAPK/ERK pathway

High expression of KIFC1 is a poor prognostic biomarker and correlates with TP53 mutation in lung cancer

KIF5A upregulation in hepatocellular carcinoma: A novel prognostic biomarker associated with unique tumor microenvironment status

Long non-coding RNA LINC01116 is overexpressed in lung adenocarcinoma and promotes tumor proliferation and metastasis